Marble Wealth’s Boston Scientific BSX Stock Holding History

Marble Wealth’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,688	Closed	-$231K	–	236
2026 Q1	$231K	Sell	3,688 -2,300	-38%	-$184K	0.04%	203
2025 Q4	$571K	Buy	+5,988	New	+$587K	0.08%	158

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Marble Wealth's BSX Position: Q2 2026 in Review

Marble Wealth sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,688 shares — an estimated $231K sold.

Marble Wealth first reported a position in BSX in Q4 2025 and held it in 2 quarters. The position peaked at $571K in Q4 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Marble Wealth reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Marble Wealth sold 3,688 Boston Scientific shares in Q2 2026, an estimated $231K.
Marble Wealth first reported a position in Boston Scientific in Q4 2025 and held it in 2 quarters.
Marble Wealth's Boston Scientific position peaked at $571K in Q4 2025.
1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Marble Wealth's 13F filing for Q2 2026, filed 7 Aug 2026.